Ovarian Cancer: The Year in Review
This could be revolutionary for the future
Scientists are attempting to remedy these issues by creating a new more consistent test used to diagnose ovarian cancer. Researchers have identified a network of circulating microRNAs, or small pieces of genetic material not responsible for DNA coding, that are significantly associated with the development of ovarian cancer. The research team then created an artificial intelligence program that could detect this microRNA network from a blood sample.
When tested, the program was able to correctly identify women who were and were not at risk for ovarian cancer. This is a huge step for ovarian cancer diagnoses since the machine could not only easily detect the disease; it would prevent false positives and inaccurate diagnoses as well.
